European Journal of Vascular & Endovascular Surgery
Volume 31, Issue 3 , Pages 266-273 , March 2006

A Preliminary Study on the Effects of Exercising to Maximum Walking Distance on Platelet and Endothelial Function in Patients with Intermittent Claudication

  • P. Collins

      Affiliations

    • Department of Vascular Surgery, Aberdeen Royel Infirmary
    • ,
  • I. Ford

      Affiliations

    • Department of Vascular Surgery, Aberdeen Royel Infirmary
    • ,
  • D. Ball

      Affiliations

    • Department of Vascular Surgery, Aberdeen Royel Infirmary
    • ,
  • E. Macaulay

      Affiliations

    • Department of Vascular Surgery, Aberdeen Royel Infirmary
    • ,
  • M. Greaves

      Affiliations

    • Department of Vascular Surgery, Aberdeen Royel Infirmary
    • ,
  • J. Brittenden

      Affiliations

    • Corresponding Author InformationCorresponding author. Dr J. Brittenden, C/O Aberdeen Royal Infirmary, Ward 36, Foresterhill, Aberdeen, Scotland AB25 2ZN, UK.
    • Department of Vascular Surgery, Aberdeen Royel Infirmary

,Accepted 5 October 2005.

References 

  1. Leng GC, Fowler B, Ernst E. Exercise for intermittent claudication cochrane peripheral vascular diseases group. Br J Surg. 2005;92(S1):9
  2. Turton EP, Coughlin PA, Kester RC, Scott DJ. Exercise training reduces the acute inflammatory response associated with claudication. Eur J Vasc Endovasc Surg. 2002;23:309–316
  3. Tisi PV, Shearman CP. The evidence for exercise-induced inflammation in intermittent claudication: should we encourage patients to stop walking?. Eur J Vasc Endovasc Surg. 1998;15:7–17
  4. Cassar K, Bachoo P, Brittenden J. The role of platelets in peripheral vascular disease. Eur J Vasc Endovasc Surg. 2003;25:6–15
  5. Cassar K, Bachoo P, Ford I, Greaves M, Brittenden J. Platelet activation is increased in peripheral arterial disease. J Vasc Surg. 2003;38:99–103
  6. Robless PA, Okonko D, Lintott P, Mansfield AO, Mikhailidis DP, Stansby GP. Increased platelet aggregation and activation in peripheral arterial disease. Eur J Vasc Endovasc Surg. 2003;25:16–22
  7. Koksch M, Zeiger F, Wittig K, Siegemund A, Reininger CB, Pfeiffer D, et al. Coagulation, fibrinolysis and platelet P-selectin expression in peripheral vascular disease. Eur J Vasc Endovasc Surg. 2001;21(2):147–154
  8. Reininger CB, Graf J, Reininger AJ, Spannagl M, Steckmeier B, Schweiberer L. Increased platelet and coagulatory activity indicate ongoing thrombogenesis in peripheral arterial disease. Thromb Res. 1996;82(6):523–532
  9. Signorelli SS, Mazzarino MC, Di Pino L, Malaponte G, Porto C, Pennisi G, et al. High circulating levels of cytokines (IL-6 and TNFalpha), adhesion molecules (VCAM-1 and ICAM-1) and selectins in patients with peripheral arterial disease at rest and after a treadmill test. Vasc Med. 2003;8(1):15–19
  10. Constans J, Seigneur M, Blann AD, Lestage B, Resplandy F, Renard M, et al. Endothelial function, platelet activation and coagulation in lower limb occlusive arterial disease during treadmill exercise: correlations with transcutaneous oxygen pressure. Thromb Res. 2000;99(6):557–561
  11. Kirkpatrick UJ, Mossa M, Blann AD, McCollum CN. Repeated exercise induces release of soluble P-selectin in patients with intermittent claudication. Thromb Haemost. 1997;78(5):1338–1342
  12. Brevetti G, De Caterina M, Martone VD, Ungaro B, Corrado F, Silvestro A, et al. Exercise increases soluble adhesion molecules ICAM-1 and VCAM-1 in patients with intermittent claudication. Clin Hemorheol Microcirc. 2001;24(3):193–199
  13. Dunlop LC, Skinner MP, Bendall LJ, Favaloro EJ, Castaldi PA, Gorman JJ, et al. Characterization of GMP-140 (P-selectin) as a circulating plasma protein. J Exp Med. 1992;175(4):1147–1150
  14. Harrison P. Platelet function analysis. Blood Rev. 2005;(19):111–12315
  15. Pasupathy S, Naseem KM, Homer Vanniasinkam S. Effect of warm-up on exercise capacity, platelet activation and platelet-leucocyte aggregation in patients with claudication. Br J Surg. 2005;92:50–55
  16. Macchi L, Brizard A, Christiaens L, Herpin D. Assessment of platelet activation after exercise using a standardized whole blood flow cytometry assay. Thromb Res. 2002;106(2):169–170
  17. Lip GTH, Blann AD. Von Willebrand factor and its relevance to cardiovascular disorders. Br Heart J. 1995;74:580–583
  18. Edwards AT, Blann AD, Suarez-Mendez VJ, Lardi AM, McCollum CN. Systemic responses in patients with intermittent claudication after treadmill exercise. Br J Surg. 1994;81:1738–1741
  19. Lewis DR, Day A, Jeremy JY, Baird RN, Smith FC, Lamont PM. The systemic effects of intermittent claudication are reversed by angioplasty. Eur J Vasc Endovasc Surg. 2001;(22):326–330
  20. Nawaz S, Walker RD, Wilkinson CH, Saxton JM, Pockley AG, Wood RF. The inflammatory response to upper and lower limb exercise and the effects of exercise training in claudicants. J Vasc Surg. 2001;33:329
  21. Pradham AD, Rifai N, Ridker PM. Soluble intercellular adhesion molecule-1, soluble vascular adhesion molecule-1 and the development of symptomatic peripheral arterial disease in men. Circulation. 2002;106:820–825
  22. Silvestro A, Scopacasa F, Oliva G, de Cristofaro T, Iuliano L, Brevetti G. Vitamin C prevents endothelial dysfunction induced by acute exercise in patients with intermittent claudication. Atherosclerosis. 2002;165:277–283
  23. Smith JW, Steinhubl SR, Lincoff AM, Coleman JC, Lee TT, Hillman RS, et al. Rapid platelet-function assay: an automated and quantitative cartridge-based method. Circulation. 1999;99(5):620–625
  24. Steinhubl SR, Talley JD, Braden GA, et al. Point of care measured platelet inhibition correlates with a reduced risk of an adverse event after percutaneous coronary intervention. Circulation. 2001;(103):2572–2578
  25. Malanin A, Spergling M, Muhlestein B, Steinbuhl S, Serebruany V. Assessing aspirin responsiveness in subjects with multiple risk factors for vascular disease with a rapid platelet function analyzer. Blood Coagul Fibrinolysis. 2004;(15):295–301
  26. de la Cruz JP, Guerrero A, Gonzalez-Correa JA, Marquez E, Nacle I, Sanchez de la Cuesta F. Effects of two preparations of 75-mg extended-release aspirin on platelet aggregation, prostanoids and nitric oxide production in humans. Eur J Clin Pharmacol. 2002;57(11):775–780
  27. Tekten T, Ceyhan C, Ercan E, Onbasili AO, Turkoglu C. The effect of atorvastatin on platelet function in patients with coronary artery disease. Acta Cardiol. 2004;59(3):311–315
  28. Coleman J, Wang JC, Simon DI. Determination of an individual response to aspirin therapy using the accumetrics Ultegra RPFA-ASSA system. Point of care. 2004;77–82
  29. Rauramaa R, Li G, Vaisanen SB. Dose-response and coagulation and hemostatic factors. Med Sci Sports Exerc. 2001;33:S516–S520[see also p. 29]
  30. Vischer UM, Wollheim CB. Epinephrine induces von Willebrand factor release from cultured endothelial cells: involvement of cyclic AMP-dependent signalling in exocytosis. Thromb Haemost. 1997;77(6):1182–1188
  31. Larsson PT, Wallen NH, Martinsson A, Egberg N, Hjemdahl P. Significance of platelet beta-adrenoceptors for platelet responses in vivo and in vitro. Thromb Haemost. 1992;68(6):687–693
  32. Malek AM, Alper SL, Izumo S. Hemodynamic shear stress and its role in atherosclerosis. JAMA. 1999;282(21):2035–2042
  33. Riddell DR, Owen JS. Nitric oxide and platelet aggregation. Vitam Horm. 1999;57:25–48
  34. Crowther M, Ford I, Jeffrey RR, Urbaniak SJ, Greaves M. Quality of harvested autologous platelets compared with stored donor platelets for use after cardiopulmonary bypass procedures. Br J Haematol. 2000;111(1):175–181
  35. Collins P, Ford I, Ball D, Macaulay E, Greaves M, Brittenden J. Surgery increases platelet aggregation in patients with severe limb ischaemia. Cochrane Database of Systematic Reviews (2):CD000990,2000.
  36. Gawaz M, Brand K, Dickfield T, Pogatsa-Murray G, Page S, Bogner C, et al. Platelets induce alterations of chemotactic and adhesive properties of endothelial cells mediated through an interleukin-1 dependent mechanism. Athersosclerosis. 2000;148:75–85
  37. Gawaz M, Neumann FJ, Dickfield T, Koch W, Laugwitz KL, Adelsberger H, et al. Activated platelets induce monocyte chemotactic protein-1 secretion and surface expression of intercellular adhesion molecule-1 on endothelial cells. Circulation. 1998;98:1164–1171
  38. Mc Bane RD, Karnicki K, Miller RS, Owen WG. The impact of peripheral arterial disease on circulating platelets. Thromb Res. 2004;113:137–145
  39. Yang J, Furie BC, Furie B. The biolgy of P-selectin glycoprotein ligand-1: its role as a selectin counterreceptor in leukocyte-endothelial and leucocyte-platelet interaction. Thromb Haemost. 1999;(81):1–7
  40. George JN, Pickett EB, Sauceman S, et al. Platelet surface glycoproteins. J Clin Invest. 1986;78:340–348
  41. Takano M, Meneshian A, Sheikh E, et al. Rapid upregulation of endothelial P-selectin expression via reactive oxygen species generation. Am J Physiol Heart Circ Physiol. 2002;283:R1014–R1030
  42. Broadley AJ, Gapper P, Schmitt M, Frenneaux MP. Supine rest reduces platelet activation and aggregation. Platelets. 2003;14:3–7

PII: S1078-5884(05)00642-8

doi: 10.1016/j.ejvs.2005.10.011

European Journal of Vascular & Endovascular Surgery
Volume 31, Issue 3 , Pages 266-273 , March 2006

Article Tools

* Image Usage & Resolution